Pharmaceutical

FDA approves drug application for Lupin’s heart failure therapy

The FDA has granted approval for the ANDA of Lupin’s Sacubitril and Valsartan Tablets for heart failure patients.

Jan 26, 2025 - 06:00
FDA approves drug application for Lupin’s heart failure therapy
The FDA has granted approval for the ANDA of Lupin’s Sacubitril and Valsartan Tablets for heart failure patients.
Read the original article

Tags:

Previous Article

Purdue and Sackler family agree to $7.4bn national opioid settlement

Next Article

Podcast: Adaptive logistics in a changing clinical landscape

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

STAT+: UnitedHealth Group now employs or is affiliated with 10% of all physicians in the U.S.

STAT+: UnitedHealth Group now employs or is affiliated ...

Nov 29, 2023

Stem cell study offers clue to South Asians’ increased risk of cardiovascular disease

Stem cell study offers clue to South Asians’ increased ...

Feb 13, 2024

STAT+: Novartis is scolded by U.K. trade group for the third time this year over Entresto marketing

STAT+: Novartis is scolded by U.K. trade group for the ...

Jul 18, 2023